Veloci
BioPharma Analyzer
The Veloci A-TEEM BioPharma Analyzer contains innovative, column-free molecular fingerprinting technology designed for the biopharma and pharma industries. By integrating the selectivity of chromatography with the benefits of optical spectroscopy, Veloci offers a fast, simple, and cost-effective method for comprehensive component analysis in various industrial QC/QA life science applications.
Unlike traditional methods such as chromatography and mass spectrometry, Veloci’s A-TEEM™ Molecular Fingerprinting technology provides component analysis without time consuming and slow separations. This allows simplified workflows and drastically reduces ownership costs. This versatile tool requires no sample preparation and is suitable for a wide range of applications, including monoclonal antibody discrimination, cell media monitoring, vaccine characterization, protein stability analysis, and AAV quantification.
The Veloci A-TEEM BioPharma Analyzer enables label-free intrinsic fluorescence analysis, offering high accuracy and efficiency in research, production and QC/QA environments.
Why Choose Veloci
- Absorbance Transmittance Excitation Emission Matrix (A-TEEM) technology (Innovative and column free molecular fingerprinting technology)
- Column free composition analysis (Selectivity of chromatography with benefits of optical spectroscopy)
- Fast analysis of samples (CCD used for detection, 10x faster)
- Low detection limits (Parts per billion – sample and wavelength dependent)
Key Advantages of Veloci
A-TEEM Correction
Collects absorbance and EEM simultaneously to correct fluorescence.
Accuracy & Efficiency
Suitable for research, production, and QC
Regulatory Compliance
Meets GMP requirements under 21 CFR Part 11
One‑Click Workflow
User‑friendly, single‑click data analysis and streamlined reporting
Applications of Veloci
Monoclonal Antibodies
Inline quantification of antibody concentration and glycosylation profiles during downstream processing.
Adeno‑Associated Viruses
Characterization of capsid integrity and vector genome packaging efficiency in AAV production.
Vaccines
Monitoring antigen–adjuvant interactions and stability to ensure vaccine potency and shelf life.
Antibody‑Drug Conjugate Ratios
Precise determination of drug‑to‑antibody ratios for consistent ADC manufacturing and QC.
Protein Stability & Aggregation
Early detection of aggregation and conformational changes under thermal or chemical stress.
Bioreactor Monitoring
Real‑time tracking of cell culture fluorescence markers to optimize bioprocess performance.
Technical Specifications of Veloci
| Veloci Biopharma Analyzer | |
|---|---|
| Detection Limit | Parts per billion (sample and wavelength dependent) |
| Excitation/Absorbance Wavelength Range | 200 to 800 nm |
| Fluorescence Emission Wavelength Range | 250 to 800 nm |
| Wavelength Accuracy | +/- 1 nm |
| EEM/A-TEEM Acquisition Rate | As fast as 60 seconds (sample and wavelength dependent) |
| Optional Accessories | Remote fiber optic probe, Autosampler with flow cell |
| Minimum Sample Volume | 70 microliters |
| Sample Handling, Internal | Cuvette and solid sample holders |
| Sample Handling, External | Autosampler (96 sample maximum) |
| Light Source | Xenon arc lamp |
| Validation | Complies with US Pharmacopia |
| Dimensions (W x D x H) | 25.3 in x 18 in x 14.5 in; 642.6 mm x 457.2 mm x 368.3 mm |
| Weight | 32.72 kg (72 lbs.) |
Related Products
NOT SURE WHAT YOU ARE LOOKING FOR?
BOOK A CONSULTATION
Our experts are here to guide you to the right solution. Fill out the form and we'll get in touch shortly.